Xiaoyang Dai

2.1k total citations
44 papers, 1.3k citations indexed

About

Xiaoyang Dai is a scholar working on Molecular Biology, Organic Chemistry and Cancer Research. According to data from OpenAlex, Xiaoyang Dai has authored 44 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 13 papers in Organic Chemistry and 10 papers in Cancer Research. Recurrent topics in Xiaoyang Dai's work include Ubiquitin and proteasome pathways (8 papers), Hippo pathway signaling and YAP/TAZ (6 papers) and PI3K/AKT/mTOR signaling in cancer (4 papers). Xiaoyang Dai is often cited by papers focused on Ubiquitin and proteasome pathways (8 papers), Hippo pathway signaling and YAP/TAZ (6 papers) and PI3K/AKT/mTOR signaling in cancer (4 papers). Xiaoyang Dai collaborates with scholars based in China, France and Macao. Xiaoyang Dai's co-authors include Qiaojun He, Hong Zhu, Bo Yang, Dominique Cahard, Huihui Fang, Xiaoyu Wu, Weiguo Cao, Linlin Nie, Ji Cao and Meidan Ying and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Hepatology.

In The Last Decade

Xiaoyang Dai

44 papers receiving 1.3k citations

Peers

Countries citing papers authored by Xiaoyang Dai

Since Specialization

Citations

This map shows the geographic impact of Xiaoyang Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoyang Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoyang Dai more than expected).

Fields of papers citing papers by Xiaoyang Dai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoyang Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoyang Dai. The network helps show where Xiaoyang Dai may publish in the future.

Co-authorship network of co-authors of Xiaoyang Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoyang Dai. A scholar is included among the top collaborators of Xiaoyang Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoyang Dai. Xiaoyang Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Josephin Domain Containing 2 (JOSD2) inhibition as Pan-KRAS-mutation-targeting strategy for colorectal cancer 2025 ·Nature Communications ·Tao Yuan, Yue Liu, (unknown), Meijia Qian, Weihua Wang, Yonghao Li, Hong Zhu, (unknown), (unknown), Chenming Zeng, Xiaoyang Dai, Ronggui Hu, Tianhua Zhou, Qiaojun He, Bo Yang	2
2	Josephin domain containing 2 (JOSD2) promotes lung cancer by inhibiting LKB1 (Liver kinase B1) activity 2024 ·Signal Transduction and Targeted Therapy ·Tao Yuan, Chenming Zeng, Jiawei Liu, Chenxi Zhao, (unknown), Yuekang Li, Meijia Qian, (unknown), Weihua Wang, Yonghao Li, Yue Liu, Xiaoyang Dai, Jianya Zhou, Xueqin Chen, Shenglin Ma, Hong Zhu, Qiaojun He, Bo Yang	9
3	ROS filter coating scaffold protects 3D mesenchymal stem cell spheroids for dual-phase treatment of spinal cord injury 2023 ·Chemical Engineering Journal ·Jian Cao, Jiahe Wu, Jiafu Mu, (unknown), (unknown), Tianchen Huang, Teng Ma, (unknown), Xiaoyang Dai, Xuhua Wang, Shiqing Feng, Jianqing Gao	17
4	Xijiao Dihuang decoction relieves the erlotinib-induced dermatitis 2022 ·Experimental Cell Research ·Yun Zheng, (unknown), Jing Lin, Xiaoyang Dai, (unknown), Yujie Wang, (unknown)	2
5	Ceritinib increases sensitivity of AKT inhibitors to gastric cancer 2021 ·European Journal of Pharmacology ·Jian Wang, Xiaqing Xu, Tingting Wang, Qingqu Guo, Xiaoyang Dai, Hongjie Guo, Wenxin Zhang, Shuyuan Cheng, Xi Chen, Ling Ding	4
6	In vivo targeted delivery of antibodies into cancer cells with pH-responsive cell-penetrating poly(disulfide)s 2021 ·Chemical Communications ·(unknown), (unknown), (unknown), (unknown), Jiaqi Yan, Jia‐Yu Liao, Wenchao Wang, Xiaoyang Dai, (unknown), Shao Q. Yao, Su Zeng, Linghui Qian	10
7	Deubiquitinase JOSD2 stabilizes YAP/TAZ to promote cholangiocarcinoma progression 2021 ·Acta Pharmaceutica Sinica B ·Meijia Qian, Fangjie Yan, Weihua Wang, (unknown), Tao Yuan, (unknown), Chenxi Zhao, Jiao Wang, Jiabin Lu, Bo Zhang, Nengming Lin, Xin Dong, Xiaoyang Dai, Xiaowu Dong, Bo Yang, Hong Zhu, Qiaojun He	32
8	USP10 Promotes Proliferation of Hepatocellular Carcinoma by Deubiquitinating and Stabilizing YAP/TAZ 2020 ·Cancer Research ·Hong Zhu, Fangjie Yan, Tao Yuan, Meijia Qian, Tianyi Zhou, Xiaoyang Dai, Ji Cao, Meidan Ying, Xiaowu Dong, Qiaojun He, Bo Yang	133
9	Machado-Joseph Deubiquitinases: From Cellular Functions to Potential Therapy Targets 2020 ·Frontiers in Pharmacology ·Chenming Zeng, Chenxi Zhao, (unknown), Yuekang Li, Ji Cao, Meidan Ying, Jin‐Jian Lu, Qiaojun He, Bo Yang, Xiaoyang Dai, Hong Zhu	24
10	Targeting slug-mediated non-canonical activation of c-Met to overcome chemo-resistance in metastatic ovarian cancer cells 2019 ·Acta Pharmaceutica Sinica B ·Linlin Chang, Yan Hu, Yingying Fu, Tianyi Zhou, Jun You, (unknown), Lin Zheng, Ji Cao, Meidan Ying, Xiaoyang Dai, Dan Su, Qiaojun He, Hong Zhu, Bo Yang	29
11	DHFR/TYMS are positive regulators of glioma cell growth and modulate chemo-sensitivity to temozolomide 2019 ·European Journal of Pharmacology ·Mengting Zhao, Biqin Tan, Xiaoyang Dai, Yanfei Shao, Qiaojun He, Bo Yang, Jincheng Wang, Qinjie Weng	22
12	Multikinase Inhibitor CT-707 Targets Liver Cancer by Interrupting the Hypoxia-Activated IGF-1R–YAP Axis 2018 ·Cancer Research ·Hong Zhu, Dandan Wang, Tao Yuan, Fangjie Yan, Chenming Zeng, Xiaoyang Dai, Zibo Chen, Ying Chen, Tianyi Zhou, (unknown), Meidan Ying, Ji Cao, Peihua Luo, Xijie Liu, (unknown), (unknown), Qiaojun He, Bo Yang	34
13	Aspirin Inhibits Cancer Metastasis and Angiogenesis via Targeting Heparanase 2017 ·Clinical Cancer Research ·Xiaoyang Dai, Juan Yan, Xuhong Fu, Qiuming Pan, Danni Sun, Yuan Xu, Jiang Wang, Litong Nie, Linjiang Tong, Aijun Shen, Mingyue Zheng, Min Huang, Minjia Tan, Hong Liu, Xun Huang, Jian Ding, Meiyu Geng	98
14	Identification of a novel autophagic inhibitor cepharanthine to enhance the anti-cancer property of dacomitinib in non-small cell lung cancer 2017 ·Cancer Letters ·Zhenghai Tang, Wenxiang Cao, Xia Guo, Xiaoyang Dai, Jiahong Lu, Xiuping Chen, Hong Zhu, Jin‐Jian Lu	38
15	Novel Hsp90 inhibitor platycodin D disrupts Hsp90/Cdc37 complex and enhances the anticancer effect of mTOR inhibitor 2017 ·Toxicology and Applied Pharmacology ·Ting Li, Xin Chen, Xiaoyang Dai, Bin Wei, Qinjie Weng, Xiuping Chen, Defang Ouyang, Ru Yan, Zhangjian Huang, Hu‐Lin Jiang, Hong Zhu, Jin‐Jian Lu	40
16	CT-707, a Novel FAK Inhibitor, Synergizes with Cabozantinib to Suppress Hepatocellular Carcinoma by Blocking Cabozantinib-Induced FAK Activation 2016 ·Molecular Cancer Therapeutics ·Dandan Wang, Ying Chen, Zibo Chen, Fangjie Yan, Xiaoyang Dai, Meidan Ying, Ji Cao, Jian Ma, Peihua Luo, Yongxin Han, (unknown), Yinghui Sun, Hui Zhang, Qiaojun He, Bo Yang, Hong Zhu	38
17	Regio- and Stereocontrolled Nucleophilic Trifluoromethylthiolation of Morita–Baylis–Hillman Carbonates 2014 ·Synlett ·Dominique Cahard, Xiaoyang Dai	13
18	Inclusion complex of GA-13315 with cyclodextrins: Preparation, characterization, inclusion mode and properties 2012 ·Carbohydrate Polymers ·Rui Yang, Jingbo Chen, Xiaoyang Dai, Rong Huang, (unknown), (unknown), Bo Yang, Lijuan Yang, Sheng‐Jiao Yan, Hongbin Zhang, Qing Chen, Jun Lin	25
19	Purification and characterization of a xylanase from Bacillus subtilis isolated from the degumming line 2011 ·Journal of Basic Microbiology ·Gang Guo, (unknown), (unknown), Jianping Liu, Xiaoyang Dai, (unknown), (unknown), Xiangyuan Feng, Shengwen Duan, Ke Zheng, Lifeng Cheng, Yueguan Fu	20
20	One‐Pot Three‐Component Syntheses of Indoloquinolizidine Derivatives Using an Organocatalytic Michael Addition and Subsequent Pictet–Spengler Cyclization 2011 ·Chemistry - A European Journal ·Xiaoyu Wu, Xiaoyang Dai, Huihui Fang, Linlin Nie, Jie Chen, Weiguo Cao, Gang Zhao	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact